Dedicated view

After Conservative / Palliative Care

This view includes only public records whose official title or study scope explicitly states advanced, metastatic, recurrent, refractory, later-line, supportive care, or palliative. TrialBeacon makes no screening judgment, matching, or recommendation — it simply gathers the literally relevant official entries together and provides direct links to the originals. Whether a record is still open, or relevant to any individual situation, should be determined from the official original and your physician’s judgment.

Last verified 2026-08-16

Showing the verified snapshot of official records indexed on 2026-08-16. Every link opens the live original page.

Includes only public records whose official title explicitly mentions advanced / recurrent / later-line / supportive care. No recommendations, no matching — only links to the originals. Defer to the official page and your physician’s judgment.

Please read this first. A record appearing here does not mean it is open, available or appropriate for any individual. Inclusion is based only on wording in the official record — never on any judgement by this site. Discuss anything you find with your treating doctor.

All types Lung Cancer Breast Cancer Colorectal Cancer Liver Cancer Gastric Cancer Pancreatic Cancer Prostate Cancer Ovarian Cancer Esophageal Cancer Lymphoma Leukemia

Trial records retrieved live from the ClinicalTrials.gov public API.

Open to enrolment onlyPhaseSort byShowing 55 of 55

Highlight terms:

Build a discussion list0 selected

Select the public official records you want to take to your appointment, then generate a list. Nothing is ranked or recommended — the list only reproduces titles and links.

Not signed in — up to 5 records per list. Sign in for higher free limits, or see Pro for more exports.

USClinicalTrials.gov【Trial record】

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Phase 1RecruitingSource updated: Oct 1, 2026

Select this record

USClinicalTrials.gov【Trial record】

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Phase 1/2RecruitingSource updated: Oct 1, 2026

Select this record

USCNClinicalTrials.gov【Trial record】

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 2RecruitingSource updated: Oct 1, 2026

Select this record

USEUCNOTHERClinicalTrials.gov【Trial record】

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

Phase 1/2RecruitingSource updated: Oct 1, 2026

Select this record

USEUCNOTHERClinicalTrials.gov【Trial record】

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Phase 2RecruitingSource updated: Oct 1, 2026

Select this record

USEUCNOTHERClinicalTrials.gov【Trial record】

A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)

Phase 2RecruitingSource updated: Oct 1, 2026

Select this record

USEUOTHERClinicalTrials.gov【Trial record】

A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

Phase 2RecruitingSource updated: Oct 1, 2026

Select this record

USEUCNOTHERClinicalTrials.gov【Trial record】

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Phase 2/3RecruitingSource updated: Oct 1, 2026

Select this record

USEUCNOTHERClinicalTrials.gov【Trial record】

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Phase 1RecruitingSource updated: Oct 1, 2026

Select this record

USClinicalTrials.gov【Trial record】

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Phase 1RecruitingSource updated: Oct 1, 2026

Select this record

USEUCNOTHERClinicalTrials.gov【Trial record】

Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

Phase 3Active, not recruitingSource updated: Oct 1, 2026

Select this record

USClinicalTrials.gov【Trial record】

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Phase 3RecruitingSource updated: Oct 1, 2026

Select this record

USClinicalTrials.gov【Trial record】

Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Phase 2Active, not recruitingSource updated: Oct 1, 2026

Select this record

EUClinicalTrials.gov【Trial record】

HTL0039732 in Participants With Advanced Solid Tumours

Phase 1/2RecruitingSource updated: Oct 1, 2026

Select this record

USOTHERClinicalTrials.gov【Trial record】

NCI COVID-19 in Cancer Patients, NCCAPS Study

Active, not recruitingSource updated: Oct 1, 2026

Select this record

USEUOTHERClinicalTrials.gov【Trial record】

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Phase 1RecruitingSource updated: Oct 1, 2026

Select this record

USClinicalTrials.gov【Trial record】

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Phase 3RecruitingSource updated: Oct 1, 2026

Select this record

USClinicalTrials.gov【Trial record】

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Phase 2RecruitingSource updated: Oct 1, 2026

Select this record

EUClinicalTrials.gov【Trial record】

Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures

Not applicableActive, not recruitingSource updated: Oct 1, 2026

Select this record

EUCNOTHERClinicalTrials.gov【Trial record】

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

Phase 1/2RecruitingSource updated: Oct 1, 2026

Select this record

USEUOTHERClinicalTrials.gov【Trial record】

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Phase 1Active, not recruitingSource updated: Oct 1, 2026

Select this record

USEUOTHERClinicalTrials.gov【Trial record】

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Phase 1RecruitingSource updated: Oct 1, 2026

Select this record

USOTHERClinicalTrials.gov【Trial record】

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Phase 2Active, not recruitingSource updated: Oct 1, 2026

Select this record

USOTHERClinicalTrials.gov【Trial record】

Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Phase 3Active, not recruitingSource updated: Oct 1, 2026

Select this record

USClinicalTrials.gov【Trial record】

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

Phase 2/3Active, not recruitingSource updated: Oct 1, 2026

Select this record

USOTHERClinicalTrials.gov【Trial record】

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

Phase 3Active, not recruitingSource updated: Oct 1, 2026

Select this record

OTHERClinicalTrials.gov【Trial record】

TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors

Phase 1RecruitingSource updated: Oct 1, 2026

Select this record

USOTHERClinicalTrials.gov【Trial record】

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Phase 1Active, not recruitingSource updated: Sep 30, 2026

Select this record

USClinicalTrials.gov【Trial record】

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

Phase 3RecruitingSource updated: Aug 14, 2026

Select this record

USClinicalTrials.gov【Trial record】

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

Phase 1RecruitingSource updated: Aug 14, 2026

Select this record

USClinicalTrials.gov【Trial record】

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

Phase 2RecruitingSource updated: Aug 14, 2026

Select this record

USClinicalTrials.gov【Trial record】

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease

Phase 1Not yet recruitingSource updated: Aug 14, 2026

Select this record

USClinicalTrials.gov【Trial record】

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

Phase 1Active, not recruitingSource updated: Aug 14, 2026

Select this record

CNClinicalTrials.gov【Trial record】

Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion

Phase 2Active, not recruitingSource updated: Aug 14, 2026

Select this record

USClinicalTrials.gov【Trial record】

Esomeprazole and Radiation Induced Esophagitis

Phase 2RecruitingSource updated: Aug 14, 2026

Select this record

USClinicalTrials.gov【Trial record】

Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer

Phase 2RecruitingSource updated: Aug 14, 2026

Select this record

USClinicalTrials.gov【Trial record】

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

Phase 3Active, not recruitingSource updated: Aug 14, 2026

Select this record

USClinicalTrials.gov【Trial record】

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Phase 1/2RecruitingSource updated: Aug 14, 2026

Select this record

OTHERClinicalTrials.gov【Trial record】

Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study

Phase 1Not yet recruitingSource updated: Aug 14, 2026

Select this record

USClinicalTrials.gov【Trial record】

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

Phase 2Active, not recruitingSource updated: Aug 14, 2026

Select this record

USClinicalTrials.gov【Trial record】

A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies

Phase 1Active, not recruitingSource updated: Aug 13, 2026

Select this record

USClinicalTrials.gov【Trial record】

A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

Phase 1/2Active, not recruitingSource updated: Aug 13, 2026

Select this record

OTHERClinicalTrials.gov【Trial record】

ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)

Phase 2Not yet recruitingSource updated: Aug 13, 2026

Select this record

USClinicalTrials.gov【Trial record】

Harvesting Cells for Experimental Cancer Treatments

Enrolling by invitationSource updated: Aug 13, 2026

Select this record

CNClinicalTrials.gov【Trial record】

JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation

Phase 3RecruitingSource updated: Aug 13, 2026

Select this record

USClinicalTrials.gov【Trial record】

Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer

Phase 1Active, not recruitingSource updated: Aug 13, 2026

Select this record

USClinicalTrials.gov【Trial record】

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

Phase 2RecruitingSource updated: Aug 13, 2026

Select this record

USClinicalTrials.gov【Trial record】

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Phase 2RecruitingSource updated: Aug 13, 2026

Select this record

CNChiCTR【Guideline / public regulatory information】

ChiCTR — Chinese Clinical Trial Registry, public search

Index verified: Aug 16, 2026

Select this record

EUCTIS【Guideline / public regulatory information】

CTIS public register — search clinical trials authorised in the EU/EEA

Index verified: Aug 16, 2026

Select this record

EUESMO【Guideline / public regulatory information】

ESMO Clinical Practice Guidelines — supportive and palliative care section

Index verified: Aug 16, 2026

Select this record

USFDA【Guideline / public regulatory information】

FDA — expanded access (compassionate use) information for patients

Index verified: Aug 16, 2026

Select this record

USNCCN【Guideline / public regulatory information】

NCCN Guidelines — palliative care category listing

Index verified: Aug 16, 2026

Select this record

USNCCN【Guideline / public regulatory information】

NCCN Guidelines for Patients — plain-language versions

Index verified: Aug 16, 2026

Select this record

CNCDE【Guideline / public regulatory information】

药物临床试验登记与信息公示平台 — national registry of drug trials conducted in China

Index verified: Aug 16, 2026

Select this record

Whether a record is still open, current, or appropriate for any individual can only be confirmed by the official source and your treating doctor.

Ways to open the conversation with your doctor (reference only, not advice)

A template only — it teaches how to ask, and gives no answers. Adapt these to your own situation.

Are these public records still searchable or open to enrolment?
From the literal wording of the public titles, is there any point relevant to the current situation?
If there is something relevant, what should I ask you about next?
For symptoms, pain or supportive care, is there a public guideline worth prioritising as a reference?

These are only examples to help you start a conversation. They are not medical advice. All decisions should be made together with your treating doctor.